Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Loss and Comprehensive loss

v2.4.0.6
Consolidated Statements of Loss and Comprehensive loss (USD $)
In Thousands, except Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Consolidated Statements of Loss and Comprehensive loss [Abstract]      
COLLABORATION REVENUE (note 2 and 4) $ 20,095 $ 5,496 $ 13,616
EXPENSES      
Research and development 39,948 21,553 18,483
General and administrative 7,791 6,230 5,840
Restructuring (gain) expense [note 7] (1,657)   4,038
Total Operating expenses 46,082 27,783 28,361
OTHER INCOME (EXPENSE)      
Interest income 292 220 86
Other 138 6 6
Warrant issuance costs     (1,027)
Gain on warrants 4,459 7,388 96
Total other income (expense) 4,889 7,614 (839)
Loss for the period before taxes (21,098) (14,673) (15,584)
Income tax recovery [note 10]     (3,000)
Net loss attributable to common shareholders (21,098) (14,673) (12,584)
OTHER COMPREHENSIVE INCOME (LOSS)      
Net unrealized income (loss) on securities 1 31 (35)
Total other comprehensive income (loss) 1 31 (35)
Total comprehensive loss attributable to common shareholders $ (21,097) $ (14,642) $ (12,619)
Basic and diluted net loss per common share [note 11[h]] $ (1.56) $ (1.51) $ (1.79)
Weighted average number of common shares [note 11[h]] 13,522,723 9,729,340 7,030,903